Purchase Order HHSD2002017M92827P
- Not listed
- This federal contract award to Pacific Biosciences of California, Inc. is for the provision of supplies related to SMRT sequencing technology. The $142,982.42 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services and has a period of performance ending on March 31, 2016. Pacific Biosciences is the original equipment manufacturer for their proprietary Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by...
- This contract award is to Pacific Biosciences of California, Inc., a for-profit manufacturer, for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms and associated consumables to the Centers for Disease Control and Prevention (CDC). The $250,000.00 firm-fixed price purchase order has a performance period ending on December 31, 2025. Pacific Biosciences has established itself as a key supplier of specialized sequencing solutions to various federal agencies, as evidenced by...
- This federal contract award, valued at $84,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Pacific Biosciences of California, Inc. for a service agreement related to their Pacific Biosciences RS DNA Sequencer. The contract is a firm fixed-price purchase order without a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to support...
- This is a firm-fixed price contract award to Pacific Biosciences of California, Inc. by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services. The $105,940 contract is for the provision of PacBio reagents, which are used in Pacific Biosciences' proprietary Sequel and Sequel II DNA/RNA sequencing platforms. These specialized sequencing systems and associated consumables are utilized by various federal civilian and defense agencies to support genomic research...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Pacific Biosciences of California, Inc., a for-profit manufacturer of specialized scientific equipment, reagents, and services. The $357,500.00 contract is for the provision of Pacific Biosciences' Sequel system, which includes the Sequel DNA/RNA sequencing instrument and associated consumables. The contract has no set-aside designation and is to be performed in...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $193,000.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to upgrade their PacBio Sequel System. This contract does not have a set-aside designation. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA sequencing systems. They have fulfilled over $10 million in federal...
- The U.S. government awarded a purchase order valued at $8,650 to Pacific Biosciences of California, Inc. for a Sequel Sequencing Kit on February 16, 2017, with completion by February 17, 2017. The contract was awarded on a firm fixed price basis with no set-aside designation to a civilian federal agency identified as Plains Area. Performance was established at Pacific Biosciences' location in Menlo Park, California. This award represents a direct procurement of sequencing reagents and...
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
- This federal contract award was made by the National Human Genome Research Institute, a civilian agency, to Pacific Biosciences of California, Inc., a for-profit manufacturer of scientific equipment. The $84,000 firm-fixed price purchase order is for the delivery of Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and support services. Pacific Biosciences has established itself as a key supplier of specialized long-read sequencing solutions to...
- This is a federal contract award to Pacific Biosciences of California, Inc., a for-profit biotechnology company that specializes in high-throughput DNA and RNA sequencing technologies. The contract, valued at $15,047.06, was awarded by the Plains Area division of the U.S. Department of Agriculture (USDA) Agricultural Research Service, a civilian agency. The contract is for the provision of PacBio's SMRT DNA sequencing platforms, reagents, consumables, and associated services to support genomic...
This federal contract award to Pacific Biosciences of California, Inc. is for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms, associated reagents, and support services. The $84,000.00 purchase order was issued by the Centers for Disease Control and Prevention (CDC) and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology. The company has established itself as a key supplier of specialized sequencing solutions to various federal civilian and defense agencies, with numerous prime and sub-contract awards to support genomic research initiatives across fields such as agriculture, infectious diseases, and biotechnology. In addition to this purchase order, Pacific Biosciences holds two significant Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicles - a $13.5 million single-award IDIQ with the USDA Agricultural Research Service, and a $1 million single-award IDIQ with the FDA. These IDIQs demonstrate the ongoing demand for Pacific Biosciences' long-read sequencing technology across federal agricultural and biomedical research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $84.0k | 1/10/17 |